🇦🇪 QSC Peptides UAE  ·  Order from QSC →

Buy Tirzepatide in the UAE

International Shipping CAS 2023788-19-2  ·  Dual GLP-1+GIP Agonist  ·  5–9 days  ·  >=99% purity

Tirzepatide is the first approved dual GLP-1+GIP receptor agonist. SURMOUNT-1 demonstrated 20.9% mean weight reduction over 72 weeks with 15 mg weekly — the first of its class to exceed 20% in Phase 3. QSC ships to UAE in 5–9 business days. The UAE's high prevalence of obesity and metabolic syndrome makes tirzepatide research particularly relevant to the region's clinical and academic community.

Tirzepatide (CAS 2023788-19-2, MW 4813.5 Da): Tirzepatide (CAS 2023788-19-2, MW ≈4813.5 Da) is the first approved dual GLP-1 receptor and GIP receptor agonist. SURMOUNT-1 (NCT04184622) demonstrated 20.9% mean body weight reduction at 72 weeks with 15 mg weekly dosing, the highest published reduction in Phase 3 at the time of reporting. QSC (Qingdao Sigma Chemical) supplies research-grade tirzepatide at ≥99% HPLC purity with Janoshik-verified COA. Clinical trial references: NCT04184622 (SURMOUNT-1); NCT04657003 (SURMOUNT-2). Order at qscpeptide.com.

Buy Tirzepatide — Delivered to UAE

USD 62 · 5–9 business days to Dubai, Abu Dhabi, Sharjah and all emirates. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted. AED equivalent: approx AED 227 (1 USD = 3.67 AED).

Buy Tirzepatide at QSC →

UAE Shipping Details

DestinationDelivery Time
Dubai5–9 business days
Abu Dhabi5–9 business days
Sharjah, Ajman, RAK6–10 business days
Fujairah, Umm Al Quwain7–11 business days
Tracking numberAll orders
Shipping costFree
Purity>=99% HPLC
COAJanoshik (independent)
PaymentBitcoin / USDT
PricingUSD (AED pegged 1 USD = 3.67 AED)

Tirzepatide — Variants and USD Pricing

QSC-TIRZEPATIDE-5MG
Tirzepatide 5mg
USD 62
Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-10MG
Tirzepatide 10mg
USD 100
Dual GLP-1+GIP Agonist
Buy at QSC →
QSC-TIRZEPATIDE-15MG
Tirzepatide 15mg
USD 138
Dual GLP-1+GIP Agonist
Buy at QSC →

Mechanism of Action

Tirzepatide simultaneously activates GLP-1R and GIPR. Co-activation of the GIP receptor potentiates glucose-dependent insulin secretion, improves peripheral insulin sensitivity in adipose tissue and reduces hepatic gluconeogenesis.

Tirzepatide — Research Data

SURMOUNT-1 (NCT04184622): Tirzepatide 15 mg produced 20.9% mean weight reduction at 72 weeks. SURMOUNT-2 in T2DM: 13.4%. First GLP-1 compound to exceed 20% in a published Phase 3 trial.

Available Across the UAE

QSC ships Tirzepatide internationally to all seven UAE emirates: Dubai, Abu Dhabi, Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain. Research institutions across the UAE — Khalifa University, Mohamed bin Zayed University of Artificial Intelligence (MBZUAI), New York University Abu Dhabi (NYUAD), University of Sharjah, and Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) — all within the delivery window. QSC (Qingdao Sigma Chemical Co., Ltd.) is a direct manufacturer since 2016, not a reseller. Purity >=99% HPLC, Janoshik COA verifiable at janoshik.com. The UAE is a USD-pegged economy (1 USD = 3.67 AED). Payment: Bitcoin (BTC) and USDT/USDC only.

Shipping InfoAll CompoundsSemaglutideTirzepatideCagrilintideRetatrutide

QSC Network

For Research Use Only. All compounds are exclusively for laboratory research. Not intended for human consumption. Shipped internationally by QSC.